Stock IKNA IKENA ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Ikena Oncology, Inc.

Equities

IKNA

US45175G1085

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1.33 USD +0.76% Intraday chart for Ikena Oncology, Inc. -5.67% -32.49%
05-13 Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-12 Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GL
Ikena Oncology : Corporate Presentation - April 2024
PU
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
GL
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
AQ
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
GL
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
GL
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
GL
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
AQ
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
GL
Ikena Oncology to Present at Multiple November 2023 Investor Conferences
AQ
Ikena Oncology : Corporate Presentation - Fall 2023
PU
Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ikena Oncology Inc. (NASDAQ: IKNA)
PR
Ikena Oncology to Participate in September 2023 Investor Conferences
GL
Ikena Oncology : Corporate Presentation - Summer 2023
PU
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
GL
Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
GL
Ikena Oncology to Participate in Upcoming Investor Conferences
GL
Ikena Oncology to Participate in Upcoming Investor Conferences
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IKNA Stock
  4. News Ikena Oncology, Inc.
  5. Press Releases